Blend Labs (BLND) Insider Investments Buys $437K of Stock
L.P. Haveli Investments purchased 256,928 shares of BLND, valued at $436,777.6.
Reviewed by automated data checks against the source filing. How we make and check alerts
L.P. Haveli Investments bought 256,928 shares of Blend Labs, Inc. ($BLND) at an average price of $1.70, worth about $436,777.60, on June 12, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $BLND is down 0.6% after 1 week, up 3.0% after 1 month and down 46.8% to date (from the $1.69 close on Jun 12, 2026).
BLND
Blend Labs, Inc.
Key Points
- L.P. Haveli Investments acquired 256,928 shares of BLND at $1.70 per share on June 12, 2026.
- BLND shares are trading near $1.69, with various institutional investors adjusting their holdings.
- Analysts have maintained ratings with targets ranging from $1.9 to $5.0 for BLND.
Get $BLND trade alerts by text
We text you when insiders, Congress or big funds trade $BLND. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Blend Labs, Inc. alert may contain errors. Disclosures
On June 12, 2026, L.P. Haveli Investments made a significant move by purchasing 256,928 shares of BLND at an average price of $1.70 per share. This transaction was valued at approximately $436,777.6 and was not part of a pre-planned trading program.
Other Institutional Activity in BLND
Several other institutional investors have also been active in BLND. Lightspeed Management Company, L.L.C. held steady with 23,127,237 shares valued at about $39.3 million. BlackRock, Inc. trimmed its position by 65,730 shares, bringing its total to 16,287,185 shares worth approximately $27.7 million. Cypress Point Investment Management LP increased its stake by 2,689,208 shares, ending with 14,537,172 shares valued at $24.7 million. Haveli Investment Management LLC maintained its position with 10,848,873 shares valued at $18.4 million. Meanwhile, Vanguard Capital Management LLC and Vanguard Portfolio Management LLC each established new positions, holding 9,652,446 and 6,702,947 shares, respectively.
Blend Labs, Inc. Stock Up 69.0%
Shares of BLND are currently trading near $1.69. The stock has seen various movements from institutional investors, reflecting ongoing interest in its performance.
Insider Buying and Selling at Blend Labs, Inc.
BLND has seen insider activity with Haveli Investments, L.P. purchasing 650,000 shares on June 15, 2026, and 256,928 shares on June 12, 2026. Additionally, Eric Woersching bought 50,000 shares on June 11, 2026. On the same day, Gerald Chen, Erin Lantz, and Bryan Edmund Sullivan each sold 50,000 shares.
Analysts Set New Price Targets
Analyst firms have maintained their ratings for BLND, with Canaccord Genuity and Citizens both maintaining a 'buy' rating. Canaccord Genuity set a price target of $4.50 on May 15, 2026, while Citizens set a target of $4.00 on May 8, 2026. Keefe, Bruyette & Woods and UBS maintained 'hold' ratings with price targets of $1.90 and $2.00, respectively.
Bottom Line
L.P. Haveli Investments' purchase of BLND shares indicates a strategic interest in the company. While BLND's stock price is currently modest, the activity from both institutional investors and analysts suggests a keen interest in its potential. As always, it's important to remember that insider and institutional activity is backward-looking and may not reflect current positions.
Related Filing Alerts
Source: L.P. Haveli Investments's Form 4 filing on $BLND (Jun 12, 2026). Find the original filing: BLND Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts